Full-Time

Quality Assurance Engineer

Updated on 9/8/2026

Deadline 9/4/27
RWS

RWS

5,001-10,000 employees

AI-powered language services and localization

No salary listed

Dublin, Ireland

Hybrid

Hybrid work arrangement indicated.

Category
QA & Testing (1)
Required Skills
Agile
Python
JavaScript
MySQL
Software Testing
Postman
SQL
Postgres
Quality Assurance (QA)
JIRA
Playwright
SCRUM
Selenium
DevOps

Get referred to RWS

See people who can refer or advise you

Requirements
  • At least 3 years of relevant quality assurance or quality engineering experience, with a strong understanding of software testing techniques and processes, including test case development and execution.
  • Experience working with and maintaining automation frameworks such as Robot Framework, Selenium, Playwright, or similar tools.
  • Ability to automate functional user interface and application programming interface tests.
  • Experience writing clear, concise, and comprehensive test plans and test cases.
  • Experience with Xray or similar test case management tools.
  • Experience using test management and project management tools such as GitLab, JIRA/Xray, or ALM.
  • Experience testing application programming interfaces, both functional and non-functional, using tools such as Postman.
  • Experience working in an Agile/Scrum environment with a good understanding of Agile principles.
  • Experience preparing test results and reports for upper management to track testing progress.
  • Ability to identify, report, and manage quality assurance-related risks.
  • Ability to define, communicate, and implement process improvements.
  • Strong organisational and task management skills, including the ability to manage competing priorities and deadlines.
  • Excellent written and verbal communication skills.
  • Proven decision-making capabilities.
  • Ability to take ownership of quality activities and work independently while contributing effectively to a small quality engineering team.
  • Ability to organise personal work and manage time effectively.
Responsibilities
  • Work closely with quality teams and analysts within Propylon to ensure client releases are robust before user acceptance testing.
  • Manage defects throughout the software development life cycle by executing functional and non-functional testing across multiple projects and client implementations.
  • Build functional test plans and strategies against user stories and business design documents to ensure traceability from requirements to stories to test cases.
  • Create and maintain detailed test plans and test cases, ensuring appropriate coverage and traceability across requirements, stories, and business design documents.
  • Participate in planning and executing regression test coverage for each release.
  • Manage and expand business regression test suites and ensure appropriate regression coverage across multiple implementations.
  • Work with quality test leads to design and implement the overall test automation strategy for client implementations, with particular attention to maintenance.
  • Run and report results from automated test suites and maintain and update automated test scripts and frameworks.
  • Automate functional user interface and application programming interface tests and contribute to the ongoing development and improvement of automation frameworks.
  • Work with product and project teams to estimate, prioritise, plan, and coordinate testing activities.
  • Work with internal project team members to identify and resolve technical issues.
  • Collect, analyse, and report quality assurance-related metrics, providing progress updates to management and product and project stakeholders.
  • Act on and track lessons learned from one release to the next across multiple implementations.
  • Ensure quality standards and processes are consistently followed while identifying and taking ownership of opportunities to improve and optimise testing processes.
  • Participate in quality-driven activities with external clients, representing the quality assurance team and supporting user acceptance testing phases when required.
  • Participate actively in peer review sessions to ensure consistently high-quality work across the team.
Desired Qualifications
  • A certified testing qualification such as ISTQB or ICAgile.
  • Programming experience, preferably in Python or JavaScript.
  • Experience with robotic process automation libraries within Python.
  • Experience with XML processing.
  • Working knowledge of SQL-based relational database management systems such as PostgreSQL or MySQL.
  • Experience with document management or document workflow software.
  • Familiarity with DevOps workflows and principles for building automated testing suites on continuous integration and continuous delivery pipelines.
  • Experience with office applications, including macros and spreadsheet formulas.
  • Experience working with JIRA.
  • Experience working in an Agile team.

RWS Holdings plc provides language services and technology solutions on a global scale for sectors including aerospace, defense, automotive, life sciences, and more. Its offerings span localization, content management, artificial intelligence, and intellectual property, delivered through AI-powered language services paired with human expertise. Clients engage through service contracts and technology licensing to enable multilingual digital experiences and streamline processes. The company differentiates itself by serving a wide range of industries with tailored, compliant solutions that integrate AI, content management, and IP capabilities under one umbrella. Its goal is to help businesses overcome language barriers and optimize operations across multilingual environments.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Chalfont St Peter, United Kingdom

Founded

1958

Get referred to RWS

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • FY26 H1 revenue reached £360.3 million, with organic constant-currency growth near 7%.
  • RWS bought Obviously on 5 May 2026 and Acolad on 3 August 2026.
  • Trados Studio 2026 launched 2 July 2026, boosting retention among 250,000 translators.

What critics are saying

  • Acolad integration completes by 31 March 2027, exposing RWS to consultation and regulatory delays.
  • Transform declined in H1 2026, showing legacy localization work still drags growth.
  • OpenAI, Google, and DeepSeek commoditize translation, crushing margins and threatening RWS's core franchise.

What makes RWS unique

  • RWS owns Trados and Language Weaver, a workflow moat translators already use daily.
  • Its 2026 M-GATE benchmark and linguist data sharpen enterprise AI selection.
  • Regulated-life-sciences and IP workflows lock in customers through compliance-heavy switching costs.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Remote Work Options

Company News

PR Newswire
Aug 25th, 2026
Frontier AI models score worse than coin flip on grammar in some languages, RWS benchmark shows

RWS has launched M-GATE, an independent benchmark measuring how well 70 AI models handle grammar, translation and efficiency across 30 languages. The benchmark reveals significant blind spots: some leading models score below 50% — worse than random guessing — on grammar tests in certain languages. Google's Gemini 3.1 Pro Preview currently leads overall grammar performance, whilst OpenAI's GPT-5.5 tops translation accuracy. However, no single model excels across all languages. xAI's Grok 4.20 performs best on Fijian grammar, but GPT-5.5 falls below chance on the same language, and Meta's Muse Spark scores just 23%. M-GATE evaluates models using linguist-designed "stumper" sentences and roundtrip translation tests. RWS's CEO Vasagi Kothandapani said the benchmark helps enterprises "choose the right model with confidence" rather than relying on unverified language support claims.

Rockworth
Aug 7th, 2026
Rockworth's H1 review.

Rockworth's H1 review. With four completed deals announced, and continued buyer appetite for high-quality acquisitions, it's been a strong start to 2026. August 7, 2026 The first half of 2026 has seen continued activity across the mid-market, with high-quality businesses attracting interest from both strategic acquirers and financial investors. At Rockworth, Rockworth Management Partners Ltd has supported clients across a broad range of sectors and transaction types. In this H1 review, Rockworth Management Partners Ltd highlight four successful transactions Rockworth Management Partners Ltd has announced so far this year. These deals demonstrate the range of objectives that can be achieved through a carefully considered transaction, whether that means securing an exit, supporting the next phase of growth, or enabling shareholders to focus on other strategic priorities. Rockworth acted as lead sell-side adviser to the shareholders of legal technology business Obviously on its sale to RWS Holdings plc, a listed AI solutions group. The deal comprises £16.5m of initial cash consideration and up to £23.5m of contingent consideration payable over three years, taking the total potential consideration to £40m. Rockworth acted as lead adviser to the shareholders of Fendequip, a manufacturer of mooring products for superyachts, on its investment partnership with Trusta Industries. Trusta is a UK industrial group with a "buy and own forever" philosophy. The founders will continue to lead Fendequip, with strategic support from Trusta, as the business enters its next phase of growth. Rockworth advised DGL International on the sale of the Craig & Rose brand to Benjamin Moore, the premium paint and coatings company owned by Berkshire Hathaway. The transaction brings together two heritage paint brands and supports Benjamin Moore's international growth ambitions. It also enables DGL International to focus on other strategic priorities across the UK and Europe. Rockworth advised the shareholders of Tolley, a specialist consultancy, on the sale of their business to G&L Scientific Group. Tolley supports pharmaceutical and biotech companies through health technology assessment and reimbursement, including submissions to NICE and the Scottish Medicines Consortium. The management team will continue to lead the business as part of G&L Scientific's expanding group of market access consultancies across Europe. With momentum in M&A continuing into the second half of 2026, Rockworth Management Partners Ltd expect strong businesses with clear growth prospects to remain attractive to both strategic and financial buyers. If you are considering selling your business, securing investment or exploring other strategic options, its team would welcome a confidential, no-obligation conversation about your objectives and the opportunities available Get the latest news from Rockworth, plus guidance on topics including building value, raising investment and selling businesses.

NewsnReleases
Aug 3rd, 2026
RWS Holdings to acquire European language services firm Acolad for $28.4M

RWS Holdings, a London-listed AI solutions company, has agreed to acquire Acogroup, parent company of language services provider Acolad, for £22.4 million ($26 million) in enterprise value. Total consideration is £40.2 million, including roughly £17.8 million for cash held at closing. Founded in 1995 and headquartered near Paris, Acolad operates across 22 countries in Europe and North America with about 1,200 employees. The company reported revenue of £182 million and adjusted EBITDA of £13 million for the year ending 31 December 2025. Roughly half of Acolad's revenue comes from regulated industries, whilst about 75% derives from localisation services. RWS said the deal would extend its AI platforms to more enterprise clients, particularly in Western Europe. The transaction is expected to close in the first half of RWS's 2027 fiscal year, pending regulatory approvals.

RWS
Jul 14th, 2026
RWS launches new linguistic validation service to significantly reduce clinical trial timelines.

RWS launches new linguistic validation service to significantly reduce clinical trial timelines. New service brings critical eCOA trial services together under one program team to speed global studies. Maidenhead, UK 7/14/2026 9:00:00 AM RWS (AIM: RWS.L), a global AI solutions company, today launched a new tech-enabled eCOA translation and linguistic validation service designed to help pharmaceutical companies, clinical research organizations (CROs) and eCOA providers reduce delays in global clinical trials. The service brings together COA licensing, source validation, multilingual translation, Trados-enabled eCOA migration, intelligent workflows, rater training and dedicated program management under a single, integrated operating model - delivered by one program team with end-to-end governance and a single point of accountability across the entire COA lifecycle.

PR Newswire
Jul 14th, 2026
RWS launches integrated eCOA service to speed global clinical trials

RWS, a global AI solutions company, has launched a new tech-enabled eCOA translation and linguistic validation service aimed at reducing delays in global clinical trials. The service integrates COA licensing, source validation, multilingual translation, eCOA migration, rater training, and programme management under a single operating model. The new offering addresses delays caused by managing these functions across multiple vendors. A dedicated programme team oversees the entire process, from licensing through to global deployment, providing unified governance and accountability. RWS has expanded its digital health portfolio to include rater training as part of this launch. The company is also investing in AI-powered tools to automate repetitive tasks whilst maintaining scientific rigour and regulatory compliance. RWS serves over 80 of the world's top 100 brands and is headquartered in the UK.